Lamictal XR lamotrigine regulatory update

FDA approved an sNDA for GSK's Lamictal XR lamotrigine as an add-on therapy for primary generalized tonic-clonic seizures in epileptic patients ages 13 and up. Lamictal XR already is approved for part...